Tracking symptoms for lung NTM infections
Part of Infections clinical trials.
This trial uses a simple symptom diary to monitor how people with lung NTM infections are feeling over time, either on or off antibiotics. It helps doctors understand treatment effects better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a lung infection caused by NTM bacteria diagnosed by standard guidelines
- You are 18 years or older
- You can understand and agree to take part in the study
- You are about to start antibiotics for this infection, or you and your doctor have decided not to use antibiotics
- You have not already started antibiotics for this NTM infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares the health of people with NTM lung disease (not on antibiotics) to people with bronchiectasis (who have never had NTM infection). It aims to understand how these conditions affect daily life.
This study keeps a real-world record of people in Korea with a lung infection caused by specific non-tuberculous mycobacteria (not tuberculosis). It may help researchers better understand these infections and treatment patterns by tracking patients as they start new therapy.
This study looks at the community of tiny organisms in the lungs (the lung microbiome) in people with bronchiectasis caused by NTM (non-tuberculous mycobacteria). It compares people with positive NTM cultures to people without, to better understand what’s going on in the lungs and why symptoms may differ.
This study looks at how NTM bacteria spread among people. If you have had a positive NTM test from your lungs, you may be able to help by sharing a sample for research.
This study checks whether a blood test called soluble programmed death-1 can help predict how nodular-bronchiectatic nontuberculous mycobacterial (NTM) lung disease will progress. Results may help doctors monitor patients more accurately and decide when to treat or follow more closely.
This trial follows people with cystic fibrosis to better understand how “nontuberculous mycobacteria” (a type of lung germ) spreads between healthcare visits and care settings. It may help improve future prevention and monitoring strategies for CF patients who have had these bacteria.
Hear when a new Non-Tuberculous Mycobacterial (NTM) Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.